BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18360334)

  • 1. Use of the CellSearch Circulating Tumor Cell Test for monitoring urothelial cancer: two case reports of metastatic urothelial cancer.
    Naoe M; Ogawa Y; Takeshita K; Iwamoto S; Miyazaki A
    South Med J; 2008 Apr; 101(4):439-41. PubMed ID: 18360334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
    Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
    Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumor cells in patients with urothelial cancer.
    Gallagher DJ; Milowsky MI; Ishill N; Trout A; Boyle MG; Riches J; Fleisher M; Bajorin DF
    Ann Oncol; 2009 Feb; 20(2):305-8. PubMed ID: 18836088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer.
    Okegawa T; Hayashi K; Hara H; Nutahara K; Higashihara E
    Int J Urol; 2010 Mar; 17(3):254-8. PubMed ID: 20148989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
    Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
    Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.
    Nichols AC; Lowes LE; Szeto CC; Basmaji J; Dhaliwal S; Chapeskie C; Todorovic B; Read N; Venkatesan V; Hammond A; Palma DA; Winquist E; Ernst S; Fung K; Franklin JH; Yoo J; Koropatnick J; Mymryk JS; Barrett JW; Allan AL
    Head Neck; 2012 Oct; 34(10):1440-4. PubMed ID: 22076949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
    Balic M; Dandachi N; Hofmann G; Samonigg H; Loibner H; Obwaller A; van der Kooi A; Tibbe AG; Doyle GV; Terstappen LW; Bauernhofer T
    Cytometry B Clin Cytom; 2005 Nov; 68(1):25-30. PubMed ID: 16142788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite components of a hepatocellular carcinoma with distinct immunohistochemical and metastatic features.
    Hu S; Mrak RE; Goldblatt PJ
    Conn Med; 2010 Feb; 74(2):79-83. PubMed ID: 20218042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells and circulating tumor DNA.
    Alix-Panabières C; Schwarzenbach H; Pantel K
    Annu Rev Med; 2012; 63():199-215. PubMed ID: 22053740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
    Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
    Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
    O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
    Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases.
    Giesing M; Driesel G; Molitor D; Suchy B
    BJU Int; 2012 Dec; 110(11 Pt C):E1202-11. PubMed ID: 23046102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis.
    Fan ZC; Yan J; Liu GD; Tan XY; Weng XF; Wu WZ; Zhou J; Wei XB
    Cancer Res; 2012 May; 72(10):2683-91. PubMed ID: 22454286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
    Rink M; Chun FK; Minner S; Friedrich M; Mauermann O; Heinzer H; Huland H; Fisch M; Pantel K; Riethdorf S
    BJU Int; 2011 May; 107(10):1668-75. PubMed ID: 20735381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
    Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and clinic implication of circulating tumor cell in patients with lung cancer].
    Mu XL; Li LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):313-8. PubMed ID: 15266838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.